Public Release: 

Hidradenitis suppurativa and risk of adverse cardiovascular events, death

The JAMA Network Journals

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease marked by painful abscesses that develop in areas where there are large numbers of sweat glands. These ooze pus and have an unpleasant smell. The disease has been associated with cardiovascular risk factors, such as smoking and obesity, but the risk of cardiovascular disease in patients with HS is unknown. Alexander Egeberg, M.D., Ph.D., of the University of Copenhagen, Denmark and coauthors investigated cardiovascular risk in patients with HS. Their study included 5,964 Danish patients with a hospital-based diagnosis of HS and 29,404 individuals from the general population without HS. The study analysis also compared patients with HS to 13,093 patients with severe psoriasis. The authors suggest HS was associated with increased risk of adverse cardiovascular outcomes and death from all causes; the risk of cardiovascular-associated death also was higher in patients with HS compared to the risk for patients with severe psoriasis. The study suggests HS may be a risk factor for adverse cardiovascular outcomes. "The results call for greater awareness of this association and for studies of its clinical consequences," the study concludes.


To read the full study, visit the For the Media website.

(JAMA Dermatology. Published online February 17, 2016. doi:10.1001/jamadermatol.2015.6264. Available pre-embargo to the media at

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Media Advisory: To contact corresponding author Alexander Egeberg, M.D., Ph.D., email

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.